These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27825160)

  • 1. Pathophysiology of Volumetric Muscle Loss Injury.
    Corona BT; Wenke JC; Ward CL
    Cells Tissues Organs; 2016; 202(3-4):180-188. PubMed ID: 27825160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regenerative and Rehabilitative Medicine: A Necessary Synergy for Functional Recovery from Volumetric Muscle Loss Injury.
    Greising SM; Dearth CL; Corona BT
    Cells Tissues Organs; 2016; 202(3-4):237-249. PubMed ID: 27825146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for Models of Skeletal Muscle Injury and Therapeutic Assessment.
    Willett NJ; Krishnan L; Li MT; Guldberg RE; Warren GL
    Cells Tissues Organs; 2016; 202(3-4):214-226. PubMed ID: 27825151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acellular biologic scaffold does not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss injury.
    Aurora A; Roe JL; Corona BT; Walters TJ
    Biomaterials; 2015 Oct; 67():393-407. PubMed ID: 26256250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Porcine Urinary Bladder Matrix Does Not Recapitulate the Spatiotemporal Macrophage Response of Muscle Regeneration after Volumetric Muscle Loss Injury.
    Aurora A; Corona BT; Walters TJ
    Cells Tissues Organs; 2016; 202(3-4):189-201. PubMed ID: 27825152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the potential use of functional fibrosis to facilitate improved outcomes following volumetric muscle loss injury.
    Dolan CP; Motherwell JM; Franco SR; Janakiram NB; Valerio MS; Goldman SM; Dearth CL
    Acta Biomater; 2022 Mar; 140():379-388. PubMed ID: 34843950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of skeletal muscle after volumetric muscle loss.
    Nuutila K; Sakthivel D; Kruse C; Tran P; Giatsidis G; Sinha I
    Wound Repair Regen; 2017 May; 25(3):408-413. PubMed ID: 28494512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric Muscle Loss.
    Pollot BE; Corona BT
    Methods Mol Biol; 2016; 1460():19-31. PubMed ID: 27492162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative pathophysiology following volumetric muscle loss injury in a porcine model.
    Chao T; Burmeister DM; Corona BT; Greising SM
    J Appl Physiol (1985); 2019 Jun; 126(6):1541-1549. PubMed ID: 30920884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan administration reduces fibrosis but hinders functional recovery after volumetric muscle loss injury.
    Garg K; Corona BT; Walters TJ
    J Appl Physiol (1985); 2014 Nov; 117(10):1120-31. PubMed ID: 25257876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and Physiological Consequences of Debridement of Fibrous Tissue after Volumetric Muscle Loss Injury.
    Corona BT; Rivera JC; Greising SM
    Clin Transl Sci; 2018 Mar; 11(2):208-217. PubMed ID: 29193769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early rehabilitation for volumetric muscle loss injury augments endogenous regenerative aspects of muscle strength and oxidative capacity.
    Greising SM; Warren GL; Southern WM; Nichenko AS; Qualls AE; Corona BT; Call JA
    BMC Musculoskelet Disord; 2018 May; 19(1):173. PubMed ID: 29843673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss.
    McFaline-Figueroa J; Schifino AG; Nichenko AS; Lord MN; Hunda ET; Winders EA; Noble EE; Greising SM; Call JA
    Tissue Eng Part A; 2022 Sep; 28(17-18):795-806. PubMed ID: 35620911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGC-1α overexpression partially rescues impaired oxidative and contractile pathophysiology following volumetric muscle loss injury.
    Southern WM; Nichenko AS; Tehrani KF; McGranahan MJ; Krishnan L; Qualls AE; Jenkins NT; Mortensen LJ; Yin H; Yin A; Guldberg RE; Greising SM; Call JA
    Sci Rep; 2019 Mar; 9(1):4079. PubMed ID: 30858541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Mitigation of Fibrosis in a Porcine Model of Volumetric Muscle Loss Injury.
    Corona BT; Rivera JC; Dalske KA; Wenke JC; Greising SM
    Tissue Eng Part A; 2020 Jun; 26(11-12):636-646. PubMed ID: 31856683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agent-based model provides insight into the mechanisms behind failed regeneration following volumetric muscle loss injury.
    Westman AM; Peirce SM; Christ GJ; Blemker SS
    PLoS Comput Biol; 2021 May; 17(5):e1008937. PubMed ID: 33970905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from volumetric muscle loss injury: A comparison between young and aged rats.
    Kim JT; Kasukonis BM; Brown LA; Washington TA; Wolchok JC
    Exp Gerontol; 2016 Oct; 83():37-46. PubMed ID: 27435497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Evaluation of Functional Outcomes Following Rat Volumetric Muscle Loss Injury and Repair.
    Mintz EL; Passipieri JA; Franklin IR; Toscano VM; Afferton EC; Sharma PR; Christ GJ
    Tissue Eng Part A; 2020 Feb; 26(3-4):140-156. PubMed ID: 31578935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of minced muscle graft progenitor cells to muscle fiber formation after volumetric muscle loss injury in wild-type and immune deficient mice.
    Corona BT; Henderson BE; Ward CL; Greising SM
    Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28400501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Approaches for Volumetric Muscle Loss Injury: A Systematic Review and Meta-Analysis.
    Greising SM; Corona BT; McGann C; Frankum JK; Warren GL
    Tissue Eng Part B Rev; 2019 Dec; 25(6):510-525. PubMed ID: 31578930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.